SOMERSET, N.J., April 04, 2019 (GLOBE NEWSWIRE) — MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of revenue cycle and cloud-based healthcare IT solutions, today announced the signing of The Heights Hospital for in-patient and outpatient revenue cycle management (“RCM”) services and fully customized IT solutions.
The Heights Hospital (“The Heights”) which is privately held is expected to officially open during Q2 of 2019. The Heights will serve the Houston, Texas area for both in-patient care and outpatient services. The Heights will feature 50 private rooms and most notable will be a Medical Detox Unit, Would Care Treatment and Oncology Infusion along with numerous outpatient clinics. Furthermore, the facility is building an 8,000 sq. ft Outpatient Physician Clinic with 17 treatment rooms which will be the largest physician clinic in the Heights.
“We believe that MTBC is uniquely positioned to support our technology, revenue cycle and practice management needs,” said Stephen Myers, JD, LLM, MBA, CEO of The Heights Hospital. “We are excited to launch this new relationship and look forward to leveraging MTBC’s support as we deliver in-patient and outpatient care to the Heights.”
“We are excited for the opportunity to work with The Heights Hospital as their exclusive revenue cycle management provider,” stated Al Nardi, VP Strategic Initiatives. “MTBC is pleased to offer its IT expertise as the architect of a newly-created custom solution for The Heights,” continued Nardi.
MTBC expanded its reach into the hospital space as part of a key 2018 initiative. In addition to its proprietary IT offerings and physician RCM, MTBC now provides comprehensive RCM services to hospitals for both in-patient and outpatient services.
MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Global Market under the ticker symbol “MTBCP.”
Forward Looking Statement
This press release contains various forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.
These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
Chief Financial Officer
Medical Transcription Billing, Corp.
Matt Kreps, Managing Director
Darrow Associates Investor Relations